BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
BioCircuit Technologies has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
BioCircuit Technologies's investors include National Institutes of Health, Alsora Capital, Michael W. Masters, GRA Venture Fund.
BioCircuit Technologies is headquartered in Atlanta, United States.
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
BioCircuit Technologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCircuit Technologies — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/biocircuit-technologies. Accessed November 13, 2026.
VCBacked. (2024). BioCircuit Technologies — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/biocircuit-technologies
{{cite web |title=BioCircuit Technologies — Funding & Investors |url=https://www.vcbacked.co/company/biocircuit-technologies |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at BioCircuit Technologies? Request a listing update